Patient information: uses, side effects, how to take - Raxibacumab
What is the most important information I should know about RAXIBACUMAB?
RAXIBACUMAB can cause serious side effects, including:
- Serious allergic reactions.Tell your healthcare provider right away if you have any of the following symptoms while receiving RAXIBACUMAB or after receiving RAXIBACUMAB:
- rash
- hives
- itching
- chills
- chest tightness or shortness of breath
- throat tightness or trouble breathing
- swelling of the lips, throat, or tongue
- feeling dizzy or lightheaded
What is RAXIBACUMAB?
- RAXIBACUMAB is a prescription medicine used along with antibiotic medicines to treat people with inhalational anthrax. RAXIBACUMAB can also be used to prevent inhalational anthrax disease when there are no other treatment options.
- The effectiveness of RAXIBACUMAB has been studied only in animals with inhalational anthrax. There have been no studies in people who have inhalational anthrax.
- The safety of RAXIBACUMAB was studied in healthy adults. There have been no studies of RAXIBACUMAB in pediatric patients.
- RAXIBACUMAB is not used for prevention or treatment of anthrax meningitis.
Before you receive RAXIBACUMAB, tell your healthcare provider about all of your medical conditions, including if you are:
- allergic to any of the ingredients in RAXIBACUMAB. See the end of this leaflet for a list of the ingredients in RAXIBACUMAB.
- allergic to diphenhydramine (BENADRYL).
- pregnant or planning to become pregnant. It is not known if RAXIBACUMAB will harm your unborn baby.
- breastfeeding or plan to breastfeed. It is not known if RAXIBACUMAB passes into your breast milk. You and your healthcare provider should decide if you will receive RAXIBACUMAB or breastfeed.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
How will I receive RAXIBACUMAB?
- You will be given 1 dose of RAXIBACUMAB by a healthcare provider through a vein (intravenous infusion). It takes about 2 hours and 15 minutes to give you the full dose of medicine.
- Your healthcare provider should give you a medicine called diphenhydramine (BENADRYL) before you receive RAXIBACUMAB to help reduce your chances of developing an allergic reaction from RAXIBACUMAB. BENADRYL may be given to you to take by mouth or through a vein.
- BENADRYL may make you sleepy, and you should use caution if you will be driving or operating equipment.
What are the possible side effects of RAXIBACUMAB?
RAXIBACUMAB can cause serious side effects, including:
- See “ What is the most important information I should know about RAXIBACUMAB?”
The most common side effects of RAXIBACUMAB include:
- rash
- pain in your arms or legs
- itchiness
- sleepiness
- injection site reactions, including redness and pain
- headache
Tell your healthcare provider if you have any side effect that bothers you or that does not go away. These are not all the possible side effects of RAXIBACUMAB. For more information, ask your healthcare provider.
Call your doctor for medical advice about side effects.
You may report side effects to FDA at 1-800-FDA-1088. For more information go to dailymed.nlm.nih.gov.
General information about the safe and effective use of RAXIBACUMAB.
Medicines are sometimes prescribed for purposes other than those listed in a patient information leaflet. This patient information leaflet summarizes the most important information about RAXIBACUMAB. If you would like more information, talk to your healthcare provider. You can ask your pharmacist or healthcare provider for information about RAXIBACUMAB that is written for health professionals.
What are the ingredients in RAXIBACUMAB?
Active ingredient:raxibacumab
Inactive ingredients:citric acid, glycine, polysorbate 80, sodium citrate, sucrose, Water for Injection.
Manufactured by Emergent BioDefense Operations Lansing LLC
Lansing, MI 48906
U.S. License No. 1755
For more information, go to www.emergentbiosolutions.com or call 1-800-768-2304.
BENADRYL is a trademark owned by or licensed to its owner and is not owned by or licensed to the Emergent group of companies. The maker of this brand is not affiliated with and does not endorse the Emergent group of companies or its products.
Raxibacumab and any and all Emergent BioSolutions Inc. brand, product, service and feature names, logos and slogans are trademarks or registered trademarks of Emergent BioSolutions Inc. or its subsidiaries in the United States or other countries. All rights reserved.
This Patient Information has been approved by the U.S. Food and Drug Administration. Revised: 06/2026
